MOYOM impulsa la estética regenerativa europea mediante la certificación APHRANEL® EU MDR

RegulatoryapprovedAPHRANEL®Positive

AI Analysis

Summary

MOYOM announced EU MDR certification for APHRANEL®, its regenerative aesthetics product, and established a strategic scientific collaboration with Expert2Expert to advance European regenerative aesthetics.

Outcome Details

EU MDR certification obtained for APHRANEL®

Importance:6/10

Sentiment:

0.70

EU_RegulatoryMedical_DeviceCertificationAestheticsPartnership

Read the original article

Published by PR Newswire Clinical Trials on August 3, 2026 3:20 AM

Read Original